538 results about "Nucleophile" patented technology

The invention relates to a novel strategy for the synthesis of Locked Nucleic Acid derivatives, such as α-L-oxy-LNA, amino-LNA, α-L-amino-LNA, thio-LNA, α-L-thio-LNA, seleno-LNA and methylene LNA, which provides scalable high yielding reactions utilizing intermediates that also can produce other LNA analogues such as oxy-LNA. Also, the compounds of the formula X are important intermediates that may be reacted with varieties of nucleophiles leading to a wide variety of LNA analogues.

This invention is directed to making chemical derivatives of carbon nanotubes and to uses for the derivatized nanotubes, including making arrays as a basis for synthesis of carbon fibers. In one embodiment, this invention also provides a method for preparing single wall carbon nanotubes having substituents attached to the side wall of the nanotube by reacting single wall carbon nanotubes with fluorine gas and recovering fluorine derivatized carbon nanotubes, then reacting fluorine derivatized carbon nanotubes with a nucleophile. Some of the fluorine substituents are replaced by nucleophilic substitution. If desired, the remaining fluorine can be completely or partially eliminated to produce single wall carbon nanotubes having substituents attached to the side wall of the nanotube. The substituents will, of course, be dependent on the nucleophile, and preferred nucleophiles include alkyl lithium species such as methyl lithium. Alternatively, fluorine may be fully or partially removed from fluorine derivatized carbon nanotubes by reacting the fluorine derivatized carbon nanotubes with various amounts of hydrazine, substituted hydrazine or alkyl amine. The present invention also provides seed materials for growth of single wall carbon nanotubes comprising a plurality of single wall carbon nanotubes or short tubular molecules having a catalyst precursor moiety covalently bound or physisorbed on the outer surface of the sidewall to provide the optimum metal cluster size under conditions that result in migration of the metal moiety to the tube end.

Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases associated with the proteasome. The peptide-based compounds include an epoxide or aziridine, and functionalization at the N-terminus. Among other therapeutic utilities, the peptide-based compounds are expected to display anti-inflammatory properties and inhibition of cell proliferation. Oral administration of these peptide-based proteasome inhibitors is possible due to their bioavailability profiles

The invention provides methods for synthesizing oligonucleotides using nucleoside monomers having carbonate protected hydroxyl groups that are deprotected with α-effect nucleophiles. The α-effect nucleophile irreversibly cleave the carbonate protecting groups while simultaneously oxidizing the internucleotide phosphite triester linkage to a phosphodiester linkage. The procedure may be carried out in aqueous solution at neutral to mildly basic pH. The method eliminates the need for separate deprotection and oxidation steps, and, since the use of acid to remove protecting groups is unnecessary, acid-induced depurination is avoided. Fluorescent or other readily detectable carbonate protecting groups can be used, enabling monitoring of individual reaction steps during oligonucleotide synthesis. The invention is particularly useful in the highly parallel, microscale synthesis of oligonucleotides.

Articles and methods for the use of such articles are described for use in immobilizing nucleophile-containing materials. In one aspect, the invention provides an article comprising: a substrate having a first surface and a second surface; and a phosphonitrilic tethering group affixed to the first surface of the substrate, the phosphonitrilic tethering group comprising a reaction product of a complementary functional group on the first surface of the substrate with a phosphonitrilic tethering compound. A method of immobilizing a nucleophile-containing material to a substrate is also described, the method comprising: providing a phosphonitrilic tethering compound; providing a substrate having a complementary functional group capable of reacting with phosphonitrilic tethering compound; preparing a substrate-attached phosphonitrilic tethering group by reacting the phosphonitrilic tethering compound with the complementary functional group on the substrate resulting in an ionic bond, covalent bond, or combinations thereof; and reacting the substrate-attached phosphonitrilic tethering group with a nucleophile-containing material to immobilize the nucleophile-containing material.

Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases. The activities of those Ntn having multiple activities can be differentially inhibited by the compounds described. For example, the chymotrypsinlike activity of the 20S proteasome may be selectively inhibited with the inventive compounds. The peptide-based compounds include an epoxide or aziridine, and functionalization at the N-terminus. Among other therapeutic utilities, the peptide-based compounds are expected to display anti-inflammatory properties and inhibition of cell proliferation.

The invention provides an imine coupled covalent organic framework material and a preparation method and application thereof and belongs to the technical field of porous materials. The structural formula of the imine coupled covalent organic framework material is shown in the description, and the material can be prepared by triazinyl aromatic polyamine A and alkoxy substituted aromatic aldehyde B through simple Schiff base condensation reaction. Under visible light excitation condition, the prepared imine coupled covalent organic framework material can catalyze multiple types of organic reactions, specifically for example reaction for photocatalysis of N-aryl tetrahydroisoquinoline and nucleophilic reagent. The prepared covalent organic framework material has very good chemical stability and heat stability, high specific surface area and high crystallinity, has strong visible light absorption properties, can serve as an excellent heterogeneous photocatalyst and has good industrial application prospect.

The invention provides a method for preparing hard polyurethane foam plastics from soybean oil. The method comprises the steps as follows: (1) carrying out epoxidation including the sub-steps of subjecting soybean oil and epoxidizing agent to reaction to obtain epoxidized soybean oil; (2) carrying out ring-opening reaction including the sub-steps of subjecting epoxidized soybean oil and nucleophilic reagent of reactive hydrogen to the ring-opening reaction of epoxy chemical bond in the presence of a catalyst to obtain mixed hydroxyl fatty acid glyceride; (3) carrying out alcoholysis and esterification including the sub-steps of adding alcohol, heating for alcoholysis to obtain mixed hydroxyl fatty acid monoester, i.e. soybean oil based polyol, and esterifying with organic acid and acid anhydride to generate polyester polyol; and (4) sequentially adding 80-150 weight parts of isocyanate, 0.3-4 weight parts of triethanolamine and 0.5-4 weight parts of foam stabilizer to 100 weight parts of soybean oil based polyol, intensively stirring, adding 0.5-3 weight parts of distilled water, and uniformly foaming while stirring at the high speed.

The present invention is based on the discovery that certain electron poor olefins combined with nucleophiles and a base catalyst are useful as adhesive compositions for the electronic packaging industry. In particular, the adhesive formulations set forth herein are useful as low temperature curing formulations with high adhesion to a variety of substrates. Invention formulations typically cure at about 80° C. and have a potlife of about 24 hours. The formulations cure by the well-known Michael addition reaction.

The invention provides a method for preparing a nitric oxide-releasing medical device. The method includes contacting an amine-functionalized silane residue with a substrate, e.g., a metallic substrate, contacting the amine-functionalized silane residue with a cross-linking agent, contacting at least one nucleophilic residue with the cross-linked amine-functionalized silane residue, and contacting the nucleophilic residue with nitric oxide gas. The invention also provides a method of contacting the cross-linked amine-functionalized silane residue with at least one nitric oxide-releasing functional group. Furthermore, the invention provides a medical device for delivering nitric oxide in therapeutic a concentration, wherein the device comprises a substrate having nitric oxide bound thereto through diazeniumdiolated nucleophiles bonded to silane intermediates. The silane intermediates are bonded to the substrate and are amine-functionalized and cross-linked.

Synthesis of a chemical compound having the formula A-B-C that may serve for applications such as drug delivery where A is a chemiluminescent, moiety, B is a photochromic moiety, and C is a biologically active moiety where A-B-C may serve as a prodrug. Novel synthetic methods of the present invention to form the prodrug comprised the steps of (1) forming a benzophenone, (2) forming a diaryl ethylene, (3) attaching a phthalimide moiety to at least one of the aryl groups of the ethylene to form a phthalimide-ethylene conjugate, (4) condensing two ethylene-phthalimide conjugates to form a phthalimide-pentadiene conjugate, (5) converting the phthalimide to the phthalhydrazide by reaction with hydrazine to form a carrier compound according to the present invention, and (6) reacting the carrier compound with an nucleophilic moiety of the drug to form the corresponding prodrug. Alternatively the carrier can be prepared by using the halo-substituted diaryl ethylene to make the corresponding cationic leuco dye-like compound with known methods. The cationic compound then is protected by reacting with a nucleophile and coupled with the aminophathalimide by palladium-catalyzed amination to form the protected phthalimide-pentadiene conjugate. The latter is refluxed with hydrazine to convert its phthalimide to the phthalhydrazide and acidified to give the carrier. An additional aspect of the present invention relates to the use of these compounds as antiviral agents for the treatment of viral infections such as HIV and as anticancer agents for the treatment of cancers such as bowel, lung, and breast cancer.

The invention relates to an initiation system for preparing a star branching polyisobutylene or the polymerization of a butyl rubber cation. The invention is used for a macromolecule compound obtained by the cation polymerization reaction of carbon-carbon unsaturated bond. The novel initiation system consists of an initiation-grafting agent; a co-initiation agent and a nucleophile and is used for initiating an ethylene monomer to carry out homopolymerization, segment copolymerization, star polymerization and grafting copolymerization. The material used by the initiation system is a common chemical reagent which is cheap. The gel chromatography spectrogram of the obtained polymer is distributed in an obvious double-peak way. The performance of the products is excellent. The initiation system provides a beneficial condition to the industrialization of the cation polymerization technique for the activity of various olefin compounds.

A one pot method of preparing cyclic carbonyl compounds comprising an active pendant pentafluorophenyl ester group is disclosed. The cyclic carbonyl compounds can be polymerized by ring opening methods to form ROP polymers comprising repeat units comprising a side chain pentafluorophenyl ester group. Using a suitable nucleophile, the pendant pentafluorophenyl ester group can be selectively transformed into a variety of other functional groups before or after the ring opening polymerization.

A new class of 2,2':6',2''-terpyridine-platinum (II) and substituted 2,2':6',2''-terpyridine-platinum (II) complexes in which an N- or O- or halo nucleophile is the fourth ligand to platinum. The compounds are potent intercalators of DNA. Some have antitumour activity. Some have anti-parasitic activity. A new method of preparing the complexes involves reacting a Pt complex of 1,5-cyclooctadiene with a 2,2':6',2''-terpyridine.